Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Related Articles by Review for PubMed (Select 2545340)

1.

Acid pH in tumors and its potential for therapeutic exploitation.

Tannock IF, Rotin D.

Cancer Res. 1989 Aug 15;49(16):4373-84.

3.

The relevance of tumour pH to the treatment of malignant disease.

Wike-Hooley JL, Haveman J, Reinhold HS.

Radiother Oncol. 1984 Dec;2(4):343-66. Review.

PMID:
6097949
4.

Regulation of cytoplasmic pH in phagocytic cell function and dysfunction.

Grinstein S, Swallow CJ, Rotstein OD.

Clin Biochem. 1991 Jun;24(3):241-7. Review.

PMID:
1651820
5.

Effects of hyperglycemia and hyperthermia on the pH, glycolysis, and respiration of the Yoshida sarcoma in vivo.

Dickson JA, Calderwood SK.

J Natl Cancer Inst. 1979 Dec;63(6):1371-81. Review.

PMID:
41958
6.

Na+-H+ exchanger, pH regulation and cancer.

Reshkin SJ, Cardone RA, Harguindey S.

Recent Pat Anticancer Drug Discov. 2013 Jan 1;8(1):85-99. Review.

PMID:
22738122
7.

Causes and consequences of tumour acidity and implications for treatment.

Stubbs M, McSheehy PM, Griffiths JR, Bashford CL.

Mol Med Today. 2000 Jan;6(1):15-9. Review.

PMID:
10637570
8.

Manipulating tumor acidification as a cancer treatment strategy.

McCarty MF, Whitaker J.

Altern Med Rev. 2010 Sep;15(3):264-72. Review.

9.

pH control mechanisms of tumor survival and growth.

Parks SK, Chiche J, Pouyssegur J.

J Cell Physiol. 2011 Feb;226(2):299-308. doi: 10.1002/jcp.22400. Review.

PMID:
20857482
10.

Interfering with pH regulation in tumours as a therapeutic strategy.

Neri D, Supuran CT.

Nat Rev Drug Discov. 2011 Sep 16;10(10):767-77. doi: 10.1038/nrd3554. Review.

PMID:
21921921
11.

Tumor acidity, chemoresistance and proton pump inhibitors.

De Milito A, Fais S.

Future Oncol. 2005 Dec;1(6):779-86. Review.

PMID:
16556057
12.

Protons make tumor cells move like clockwork.

Stock C, Schwab A.

Pflugers Arch. 2009 Sep;458(5):981-92. doi: 10.1007/s00424-009-0677-8. Epub 2009 May 13. Review.

PMID:
19437033
13.

A rationale for the use of proton pump inhibitors as antineoplastic agents.

De Milito A, Marino ML, Fais S.

Curr Pharm Des. 2012;18(10):1395-406. Review.

PMID:
22360553
15.

Proliferation-dependent cytotoxicity of anticancer agents: a review.

Valeriote F, van Putten L.

Cancer Res. 1975 Oct;35(10):2619-30. Review.

16.

Use of hypoxia-directed drugs in the therapy of solid tumors.

Rockwell S.

Semin Oncol. 1992 Aug;19(4 Suppl 11):29-40. Review.

PMID:
1509279
17.

Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?

Choi SY, Collins CC, Gout PW, Wang Y.

J Pathol. 2013 Aug;230(4):350-5. doi: 10.1002/path.4218. Review.

18.

Disrupting proton dynamics and energy metabolism for cancer therapy.

Parks SK, Chiche J, Pouysségur J.

Nat Rev Cancer. 2013 Sep;13(9):611-23. doi: 10.1038/nrc3579. Review.

PMID:
23969692
19.

[Effect of pH on blood cells].

Ozaki Y.

Nihon Rinsho. 1992 Sep;50(9):2112-8. Review. Japanese.

PMID:
1434000
20.

Anticancer agents that counteract tumor glycolysis.

Granchi C, Minutolo F.

ChemMedChem. 2012 Aug;7(8):1318-50. doi: 10.1002/cmdc.201200176. Epub 2012 Jun 8. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk